参考文献/References:
[1] 施杞.中医骨伤科学[M].北京:人民卫生出版社,2006:490-493.
[2] 董超,唐勇,姜维龙,等.从气血探讨骨性关节炎的病因病机与防治思路[J].新中医,2009,41(12):1-2.
[3] 乔铁,马进,梁可,等.《方剂学》中人参当归配伍规律浅析[J].现代中医药,2015,35(5):125-126.
[4] 谷远洋,严培军.人参皂苷Rg1对IL-1β诱导的人膝软骨细胞降解保护作用机制研究[J].南京中医药大学学报,2018,34(4):357-360.
[5] 刘保新,陈廖斌,汪晖,等.当归、阿魏酸钠对骨关节炎软骨退变与自由基的影响[J].武汉大学学报(医学版),2006,27(5):626-628.
[6] 贝圆,冯俭,李跃辉,等.人参-当归药对脂溶性成分的气相色谱-质谱联用研究[J].时珍国医国药,2014,25(1):81-83.
[7] 贝圆,冯俭,罗方利,等.人参当归配伍对人参中人参皂苷Rg1、Re、Rb1溶出率的影响[J].华西药学杂志,2013,28(6):619-621.
[8] 郑春松,徐筱杰,刘献祥,等.精制透骨消痛颗粒防治骨性关节炎的计算机药理学[J].物理化学学报,2010,26(3):775-783.
[9] 郑春松,叶蕻芝,叶锦霞,等.应用计算机模拟研究牛膝在骨关节炎中的痿痹同治作用[J].康复学报,2020,30(2):124-130.
[10] 郑春松,徐筱杰,叶蕻芝,等.川芎活血化瘀和行气止痛作用的计算机模拟研究[J].中华中医药杂志,2015,30(5):1432-1436.
[11] GU J,GUI Y,CHEN L,et al.Use of natural products as chemical library for drug discovery and network pharmacology[J].PLoS One,2013,8(4):e62839.
[12] RU J,LI P,WANG J,et al.TCMSP a database of systems pharmacology for drug discovery from herbal medicines[J].J Cheminform,2014,6:13.
[13] 徐筱杰.计算机辅助药物分子设计[M].北京:化学工业出版社,2004:119-121.
[14] 郑春松,范展彪,叶蕻芝,等.从化学空间探讨荣筋拈痛方补肝肾强筋骨和祛风湿止痹痛的作用[J].风湿病与关节炎,2018,7(2):33-36.
[15] 赵桂儒.较大规模数据应用PCA降维的一种方法[J].电脑知识与技术,2014,10(8):1835-1837.
[16] WANG Y,ZHANG S,LI F,et al.Therapeutic target database 2020:enriched resource for facilitating research and early development of targeted therapeutics[J].Nucleic Acids Res,2020,48(D1):D1031-D1041.
[17] CHEN C,ZHU Z,HU N,et al.Leonurine hydrochloride suppresses inflammatory responses and ameliorates cartilage degradation in osteoarthritis via NF-κB signaling pathway[J].Inflammation,2020,43(1):146-154.
[18] XIE P,DAN F,YU G,et al.Laquinimod mitigated IL-1β-Induced impairment of the cartilage extracellular matrix in human ATDC5 chondrocytes[J].Chem Res Toxicol,2020,33(4):933-939.
[19] 李超,曹永平,关振鹏,等.蛋白聚糖酶和骨关节炎[J].北京大学学报(医学版),2009,41(5):611-612.
[20] BERMAN H M,WESTBROOK J,FENG Z,et al.The protein data bank[J].Nucleic Acids Res,2000,28(1):235-242.
[21] MONTES M,MITEVA M,VILLOUTREIX B O.Structure-based virtual ligand screening with ligandfit:pose prediction and enrichment of compound collections[J].Proteins,2007,68(3):712-725.
[22] SMOOT M E,ONO K,RUSCHEINSKI J,et al.Cytoscape 2.8:new features for data integration and network visualization[J].Bioinformatics,2011,27(3):431-432.
[23] 宋福江,范斌,孙健.基于网络药理学的醒脑静注射液治疗脑梗死配伍机制研究[J].中国中药杂志,2018,43(7):1366-1372.
[24] 方杭.骨关节炎中医病因浅析[J].内蒙古中医药,2019,38(10):142-144.
[25] 沈锦涛,张英杰,郑福增,等.施杞教授以少阳主骨为立论辨治膝骨关节炎经验[J].风湿病与关节炎,2020,9(4):38-40.
[26] MAGDALOU J,CHEN L B,WANG H,et al.Angelica sinensis and osteoarthritis:a natural therapeutic Link?[J].Biomed Mater Eng,2015,25(Suppl 1):179-186.
[27] 张汉庆,肖嫚,刘勇.单味中药治疗骨性关节炎研究进展[J].中国中医骨伤科杂志,2012,20(1):65-67.
[28] 张卫东.系统生物学与中药方剂现代研究[M].北京:科学出版社,2017:5-6.
[29] YC M,KOFRON J L,TRAPHAGEN L M.Do structurally similar molecules have similar biological activity?[J].J Med Chem,2002,45(19):4350-4358.
[30] CAI C,GONG J,LIU X,et al.Molecular similarity:methods and performance[J].Chin J Chem,2013,31(9):1123-1132.
[31] DOBSON C M.Chemical space and biology[J].Nature,2004,432(719):824-828.
[32] 马杰良,安莉莉,邢雪.城市公交网络的拓扑特性分析[J].山西师范大学学报(自然科学版),2009,23(1):51-55.
[33] HENDREN L,BEESON P.A review of the differences between normal and osteoarthritis articular cartilage in human knee and ankle joints[J].Foot(Edinb),2009,19(3):171-176.
[34] TORTORELLA M D,MALFAIT A M,DECCICO C,et al.The role of ADAM-TS4(aggrecanase-1)and ADAM-TS5(aggrecanase-2)in a model of cartilage degradation[J].Osteoarthritis Cartilage,2001,9(6):539-552.
[35] 张超,王旭,姜建元,等.MMP-1、13 mRNA和DDR2表达与关节软骨退变的关系[J].复旦学报(医学版),2007,34(1):126-128.
[36] 孟祥奇,黄桂成,惠礽华,等.黄芪甲苷对人膝骨关节炎退变软骨细胞MMP-1和MMP-3mRNA表达的影响[J].辽宁中医药大学学报,2012,14(7):88-90.
[37] LIN P M,CHEN C T,TORZILLI P A.Increased stromelysin-1(MMP-3),proteoglycan degradation(3B3- and 7D4)and collagen damage in cyclically load-injured articular cartilage[J].Osteoarthritis Cartilage,2004,12(6):485-496.
[38] 李慧,马玉环,王圣杰,等.独活寄生汤抑制炎症介导软骨细胞基质降解的机制研究[J].风湿病与关节炎,2019,8(12):5-8.